Integral Derivatives’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-16,500
Closed -$1.36M 1050
2017
Q4
$1.36M Sell
16,500
-5,600
-25% -$462K 0.03% 393
2017
Q3
$1.81M Sell
22,100
-2,100
-9% -$169K 0.03% 340
2017
Q2
$1.92M Buy
24,200
+16,100
+199% +$1.23M 0.04% 313
2017
Q1
$602K Sell
8,100
-28,700
-78% -$2.09M 0.01% 691
2016
Q4
$2.54M Buy
+36,800
New +$2.55M 0.05% 261
2014
Q3
Sell
-25,000
Closed -$1.52M 1570
2014
Q2
$1.52M Buy
+25,000
New +$1.47M 0.03% 523

Other funds holding XLV

Integral Derivatives's XLV Position: Q4 2017 in Review

Integral Derivatives sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2017, closing a stake of 23,542 shares — an estimated $1.94M sold.

Integral Derivatives first reported a position in XLV in Q1 2014 and held it in 5 quarters. The position peaked at $1.92M in Q3 2017. 768 funds tracked by Wall St. Rank hold XLV as of Q4 2017.

  • Integral Derivatives reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 23,542 State Street Health Care Select Sector SPDR ETF shares in Q4 2017, an estimated $1.94M.
  • Integral Derivatives first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2014 and held it in 5 quarters.
  • Integral Derivatives's State Street Health Care Select Sector SPDR ETF position peaked at $1.92M in Q3 2017.
  • 768 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.